[Basic research and treatment for cerebral vasospasm after subarachnoid hemorrhage: the present and future prospects].
Nishizawa
Shigeru
S
Department of Neurosurgery, University of Occupational and Environmental Health, Fukuoka, Japan.
Zhang
John H
JH
D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000208:Acute Disease; D000800:Angioplasty, Balloon; D002121:Calcium Channel Blockers / Q000008:administration & dosage; D002462:Cell Membrane; D003131:Combined Modality Therapy; D019332:Endothelin-1; D006454:Hemoglobins; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000166:cytology; D009529:Nicardipine / Q000008:administration & dosage; D009569:Nitric Oxide; D018384:Oxidative Stress; D013345:Subarachnoid Hemorrhage / Q000150:complications*; D014665:Vasodilator Agents / Q000008:administration & dosage; D020301:Vasospasm, Intracranial / Q000209:etiology* / Q000628:therapy*; D014700:Verapamil / Q000008:administration & dosage
D002121:Calcium Channel Blockers; D019332:Endothelin-1; D006454:Hemoglobins; D014665:Vasodilator Agents; D009569:Nitric Oxide; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D014700:Verapamil; D009529:Nicardipine; C049347:fasudil